Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers
Clinical trial NCT02153320 · COMPLETED
Trial details
- NCT number
- NCT02153320
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-05
- Primary completion
- 2005-10-28
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.